2023 annual financial data

Arcturus Therapeutics Holdings 2023 Net margin

Direct answer

Net margin was -18.84%.

Operating income was -78,205,000 USD and net income was -29,725,000 USD.
Operating cash flow was -18,099,000 USD.

Get free Arcturus Therapeutics Holdings email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
157,748,000 USD
Operating income
-78,205,000 USD
Net income
-29,725,000 USD
Operating cash flow
-18,099,000 USD